Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

HOLX – Hologic, Inc.

Float Short %

1.97

Margin Of Safety %

19

Put/Call OI Ratio

0.73

EPS Next Q Diff

-0.03

EPS Last/This Y

2.06

EPS This/Next Y

0.44

Price

75.19

Target Price

77.2

Analyst Recom

2.85

Performance Q

18.73

Relative Volume

1.55

Beta

0.7

Ticker: HOLX




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17HOLX74.140.550.0656323
2025-11-18HOLX74.120.551.0856325
2025-11-19HOLX74.180.5527.8656304
2025-11-20HOLX74.130.562.9857012
2025-11-21HOLX74.370.571.0057074
2025-11-24HOLX74.790.740.1135177
2025-11-25HOLX74.880.720.1535913
2025-11-26HOLX74.80.720.7035908
2025-12-01HOLX74.860.720.1336028
2025-12-02HOLX74.830.721.8936025
2025-12-03HOLX750.721.0036037
2025-12-04HOLX74.860.720.0036038
2025-12-05HOLX74.970.720.2136040
2025-12-08HOLX74.850.720.0036044
2025-12-09HOLX74.90.720.1236039
2025-12-10HOLX74.840.720.0036051
2025-12-11HOLX74.840.7219.0136240
2025-12-12HOLX75.010.720.8736345
2025-12-15HOLX75.180.730.2936531
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-17HOLX74.146.2295.14.57
2025-11-18HOLX74.116.2294.94.57
2025-11-19HOLX74.176.2296.24.57
2025-11-20HOLX74.146.2292.54.57
2025-11-21HOLX74.356.2296.04.57
2025-11-24HOLX74.776.2298.94.57
2025-11-25HOLX74.886.2294.74.56
2025-11-26HOLX74.806.2291.94.56
2025-12-01HOLX74.866.2291.44.56
2025-12-02HOLX74.826.2292.44.56
2025-12-03HOLX75.016.2295.74.56
2025-12-04HOLX74.886.2291.24.56
2025-12-05HOLX74.976.5294.54.56
2025-12-08HOLX74.856.5- 4.56
2025-12-09HOLX74.896.5293.74.56
2025-12-10HOLX74.896.5292.44.56
2025-12-11HOLX74.836.5292.84.56
2025-12-12HOLX75.016.5295.54.56
2025-12-15HOLX75.196.5295.74.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-17HOLX-6.035.701.54
2025-11-18HOLX-6.035.701.54
2025-11-19HOLX-6.035.701.54
2025-11-20HOLX-5.985.701.54
2025-11-21HOLX-5.975.701.54
2025-11-24HOLX-5.97-1.341.55
2025-11-25HOLX-3.88-1.341.55
2025-11-26HOLX-3.88-1.341.77
2025-12-01HOLX-3.88-1.221.77
2025-12-02HOLX-3.88-1.221.77
2025-12-03HOLX-3.88-1.221.77
2025-12-04HOLX-3.88-1.221.77
2025-12-05HOLX-3.88-1.221.77
2025-12-08HOLX-3.88-1.301.77
2025-12-09HOLX-3.88-1.301.77
2025-12-10HOLX-3.88-1.301.97
2025-12-11HOLX-3.88-1.301.97
2025-12-12HOLX-3.88-1.301.97
2025-12-15HOLX-3.88-1.301.97
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="HOLX" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

1.13

Avg. EPS Est. Current Quarter

1.1

Avg. EPS Est. Next Quarter

1.1

Insider Transactions

-3.88

Institutional Transactions

-1.3

Beta

0.7

Average Sales Estimate Current Quarter

1073

Average Sales Estimate Next Quarter

1051

Fair Value

89.27

Quality Score

82

Growth Score

67

Sentiment Score

63

Actual DrawDown %

14.4

Max Drawdown 5-Year %

-39.9

Target Price

77.2

P/E

30.28

Forward P/E

15.03

PEG

1.77

P/S

4.09

P/B

3.32

P/Free Cash Flow

18.22

EPS

2.48

Average EPS Est. Cur. Y​

4.56

EPS Next Y. (Est.)

5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.8

Relative Volume

1.55

Return on Equity vs Sector %

-15.8

Return on Equity vs Industry %

1.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

295.7
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”HOLX” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”HOLX” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”HOLX” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”HOLX” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”HOLX” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”HOLX” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”HOLX” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Hologic, Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 7070
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
stock quote shares HOLX – Hologic, Inc. Stock Price stock today
news today HOLX – Hologic, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch HOLX – Hologic, Inc. yahoo finance google finance
stock history HOLX – Hologic, Inc. invest stock market
stock prices HOLX premarket after hours
ticker HOLX fair value insiders trading